The Insightful Corner Hub
Medical Intelligence · Est. 2012
Ontology Infrastructure

Every concept, every code, every relationship.

TICH's ontology layer normalizes every disease, symptom, pathogen, medicine, adverse event and intervention against six global standards. The same engine powers semantic search, the knowledge graph, AI grounding and regulatory cross-walks.

Indexed concepts
2.4M
Standards
6
Cross-walks
11.8M
Updated
Daily
Diabetes mellitusSGLT2 inhibitorsFournier's gangrenePlasmodium falciparumCarbapenem resistance
Clinical terminology
SNOMED CT
352,000+ concepts indexed
Cross-walked to all 5 sibling standards
Diseases & conditions
ICD-11
55,000+ concepts indexed
Cross-walked to all 5 sibling standards
Adverse events
MedDRA
84,000+ concepts indexed
Cross-walked to all 5 sibling standards
Medications & ingredients
RxNorm
270,000+ concepts indexed
Cross-walked to all 5 sibling standards
Biomedical literature
MeSH
30,000+ concepts indexed
Cross-walked to all 5 sibling standards
Drug classification
ATC
6,400+ concepts indexed
Cross-walked to all 5 sibling standards
Sample concept resolution

Entity graph · live cross-walks

Open full knowledge graph →
SNOMED CT73211009
Diabetes mellitus (disorder)
Semantic type · Disease or Syndrome
DMDiabetes
Related entities
  • treated_by
    Metformin
    RxNorm 6809
  • guideline
    ADA Standards of Care 2025
    TICH-GL
  • icd11
    5A11 · Type 2 diabetes mellitus
    ICD-11
  • complication
    Diabetic ketoacidosis
    SNOMED 420422005
Explore evidence
MedDRA PT10019805
Fournier's gangrene
Semantic type · Adverse event
Necrotizing fasciitis of perineum
Related entities
  • signal_for
    SGLT2 inhibitors
    ATC A10BK
  • regulator
    EMA PRAC 2026-117
    EMA
  • ror
    4.2 (3.1–5.7) EudraVigilance
    PV
Explore evidence
ATCA10BJ
Glucagon-like peptide-1 (GLP-1) analogues
Semantic type · Pharmacologic class
GLP-1 receptor agonists
Related entities
  • member
    Semaglutide
    RxNorm 1991302
  • indication
    Type 2 diabetes mellitus
    ICD-11 5A11
  • outcome
    Reduces 3-point MACE (HR 0.86)
    TICH evidence
Explore evidence